Latest News

Study provides new insight into regional survival differences in glioblastoma

A team of researchers from Osaka University, in cooperation with the Institute for Clinical Research and medical institutes participating in the Kansai Molecular Diagnosis Network for CNS Tumors, conducted the largest-ever retrospective cohort study for Japanese patients with glioblastoma, proposing an underlying prognosis biomarker responsible for the survival difference between two cohorts: an original Japanese cohort and a dataset from The Cancer Genome Atlas.

Source link

Related posts

Inactive Lifestyle Begins as Early as Age 7: Study


White House urges Americans to wear cloth face coverings in public in bid to slow coronavirus spread


Pregnant women with obesity may not require additional calories for healthy pregnancies


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy